FDA approves SenoClaire X Ray Imaging system-GE Healthcare

The FDA has given approval for SenoClaire, an X Ray Imaging device, from GE Healthcare, that uses breast tomosynthesis for a three-dimensional imaging. SenoClaire technology uses a low-dose short X Ray sweep around the positioned breast with nine exposures acquired with a �step-and-shoot� method, removing the potential motion from the tube helping to reduce blur and increase image sharpness.

There is also no increase in dose from a 2D standard mammogram to a 3D view, which means there is no increased radiation for patients during a breast exam. In addition, SenoClaire offers a complete solution by helping to improve overall workflow, since it is compatible with a number of data systems.